Atopic Dermatitis – P20-441
20211115142136

Real world utilization of upadacitinib in adult and adolescent patients living with moderate to severe atopic dermatitis (AD-VISE).

Irritable Bowel Syndrome – 20.01.CLI
20210913112541

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Bifidobacterium longum (BL) NCC3001 on Intestinal and Psychological Symptoms in Subjects with Irritable Bowel Syndrome (IBS)

Biogen – 230LE301/302 – Lupus
20201207134500

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations